The Technical Analyst
Select Language :
AIkido Pharma Inc. [AIKI]

Exchange: NASDAQ Capital Market Sector: Healthcare Industry: Biotechnology

AIkido Pharma Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals

AIkido Pharma Inc. is listed at the NASDAQ Exchange

0.85% $3.56

/ 22 des 2022 @ 00:00


AIkido Pharma Inc.: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 19.53 mill
EPS: 0
P/E: 0
Earnings Date: N/A
SharesOutstanding: 5.49 mill
Avg Daily Volume: 0.0353 mill
RATING 2023-02-22
B+
Neutral
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Neutral
Return On Asset: Neutral
DE: Neutral
P/E: Sell
Price To Book: Neutral
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenuen/an/an/an/an/a
Gr.Profitn/an/an/an/an/a
Ebit
Asset
Debtn/an/a
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE 0 | sector: PE 0
PE RATIO: COMPANY / INDUSTRY
N/A
Company: PE 0 | industry: PE 0
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 3.29 - 3.83

( +/- 7.58%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2023-12-26 Devall Christopher Franklin Buy 7 000 Common Stock
2023-12-26 Wool Kyle Michael Buy 5 000 Common Stock
2023-12-21 Wool Kyle Michael Buy 630 050 Common Stock
2023-12-20 Hayes Anthony Buy 70 000 Common Stock
2023-12-12 Hayes Anthony Buy 2 000 Common Stock
INSIDER POWER
100.00
Last 98 transactions
Buy: 6 932 818 | Sell: 0

Forecast: 01:40 - $3.99

Live Trading Signals (every 1 min)

SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $3.56 (0.85% )
Volume 0.0319 mill
Avg. Vol. 0.0353 mill
% of Avg. Vol 90.57 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for AIkido Pharma Inc.

Last 12 Months

Last 12 months chart data with high, low, open and close for AIkido Pharma Inc.

RSI

Intraday RSI14 chart for AIkido Pharma Inc.

Last 10 Buy & Sell Signals For AIKI

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            AIkido Pharma Inc.

AIKI

AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is headquartered in New York, New York.

Last 10 Buy Signals

Date Signal @
SFUNDUSDMar 28 - 17:53$4.37
UNFIUSDMar 28 - 17:537.51
RIOUSDMar 28 - 17:542.90
MSOLUSDMar 28 - 17:53220.98
METISUSDMar 28 - 17:55$100.67
LINKUSDMar 28 - 17:55$19.18
HAPIUSDMar 28 - 17:5423.29
AGIUSDMar 28 - 17:530.450
ENSUSDMar 28 - 17:5322.31
SUSHIUSDMar 28 - 17:54$1.828

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.